Pfizer Inc.
PFENYSEHealthcare● Active
$25.62
$-0.42(-1.61%)
Market Cap$146.0B
P/E Ratio—
52W High$28.75
52W Low$23.11
Pfizer Inc.（PFE）· 现金流量表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · PFE · 截至 2026-06-10
财务报表
Operating CF · CapEx · Free Cash Flow
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | $7.75B | $8.05B | $2.17B | $31.40B | $22.46B |
| Depreciation & Amort. | $6.59B | $7.01B | $6.29B | $5.06B | $5.19B |
| Stock-Based Comp. | $0.00B | $0.88B | $0.53B | $0.87B | $1.18B |
| Change in Working Capital | ($5.35B) | ($3.07B) | ($2.17B) | ($4.46B) | $12.80B |
| Net Cash from Operations | $11.71B | $12.74B | $8.70B | $29.27B | $32.58B |
| Investing Activities | |||||
| Capital Expenditure | ($2.63B) | ($2.91B) | ($3.91B) | ($3.24B) | ($2.71B) |
| Purchases of Investments | ($14.65B) | ($10.31B) | ($31.18B) | ($38.78B) | ($47.61B) |
| Sales of Investments | $22.69B | $8.83B | $46.42B | $45.46B | $28.10B |
| Net Cash from Investing | ($1.35B) | $2.65B | ($32.28B) | ($15.78B) | ($22.55B) |
| Financing Activities | |||||
| Common Stock Repurchased | $0.00B | $0.00B | $0.00B | ($2.00B) | $0.00B |
| Dividends Paid | ($9.77B) | ($9.51B) | ($9.25B) | ($8.98B) | ($8.73B) |
| Debt Issued / Repaid | ($0.07B) | ($7.16B) | $35.95B | ($3.52B) | ($1.10B) |
| Net Cash from Financing | ($10.30B) | ($17.14B) | $26.07B | ($14.83B) | ($9.82B) |
| Free Cash Flow | |||||
| Free Cash Flow | $9.08B | $9.84B | $4.79B | $26.03B | $29.87B |
| FCF Margin %(computed) | 14.50% | 15.46% | 8.05% | 25.95% | 36.74% |
数据来源：Financial Modeling Prep · 最后更新：2026-06-10 · USD · B
深入了解Pfizer Inc.
关于Pfizer Inc.（PFE）现金流量表
Pfizer Inc. 2025财年经营活动现金流$11.71B，自由现金流$9.08B（FCF利润率14.50%），资本支出($2.63B)。
常见问题
PFE · 4 问Pfizer Inc. 2025财年自由现金流$9.08B，同比down7.7%。
PFE free cash flowFCF margincash flow yield
· Source: FMP /stable/cash-flow-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-10